BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 10311152)

  • 21. DRGs and hospital case records: implications for Medicare case mix accuracy.
    Johnson AN; Appel GL
    Inquiry; 1984; 21(2):128-34. PubMed ID: 6237993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Institutional responses to prospective payment based on diagnosis-related groups. Implications for cost, quality, and access.
    Stern RS; Epstein AM
    N Engl J Med; 1985 Mar; 312(10):621-7. PubMed ID: 3919294
    [No Abstract]   [Full Text] [Related]  

  • 23. Medicare program; schedule of limits on hospital inpatient operating costs for cost reporting periods beginning on or after October 1, 1982--HCFA. Interim final notice with comment period.
    Fed Regist; 1982 Sep; 47(190):43296-338. PubMed ID: 10310163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An economic approach to DRGs: a reimbursement system that limits the costs of hospital care.
    Doremus HD
    Healthc Financ Manage; 1983 Apr; 37(4):86-91. PubMed ID: 10315306
    [No Abstract]   [Full Text] [Related]  

  • 25. Part 3, Responding to PPS. How hospital managers should respond to PPS.
    Averill RF; Kalison MJ; Sparrow DA; Owens TR
    Healthc Financ Manage; 1984 Mar; 38(3):72-6, 82-6. PubMed ID: 10315520
    [No Abstract]   [Full Text] [Related]  

  • 26. The ABCs of DRGs.
    RN; 1985 Jun; 48(6):55-8. PubMed ID: 3923597
    [No Abstract]   [Full Text] [Related]  

  • 27. Diagnosis related groups: their role in the reimbursement system.
    Merrill JC
    Bull N Y Acad Med; 1984 Jun; 60(5):514-24. PubMed ID: 6428494
    [No Abstract]   [Full Text] [Related]  

  • 28. Does severity of illness make a difference in prospective payment?
    Horn SD
    Healthc Financ Manage; 1983 May; 37(5):49-53. PubMed ID: 10315319
    [No Abstract]   [Full Text] [Related]  

  • 29. Case-mix data system prepares hospitals for DRG-based reimbursement.
    Burik D; Gilroy P; Mastrangelo AJ
    Hosp Prog; 1983 Feb; 64(2):47-9, 72. PubMed ID: 10309814
    [No Abstract]   [Full Text] [Related]  

  • 30. Case mix: Medicare's pitch for a new ball game in operational funding.
    Bley CM; Nackel JG
    Trustee; 1983 Apr; 36(4):14-7. PubMed ID: 10309925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medicare program: changes to the hospital inpatient prospective payment systems and fiscal year 2009 rates; payments for graduate medical education in certain emergency situations; changes to disclosure of physician ownership in hospitals and physician self-referral rules; updates to the long-term care prospective payment system; updates to certain IPPS-excluded hospitals; and collection of information regarding financial relationships between hospitals. Final rules.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2008 Aug; 73(161):48433-9084. PubMed ID: 18956499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Capital payment under PPS: can hospitals still bloom?
    Nash D; Haught JA; Hopkins A; Oxler K; Rovinsky M
    Healthc Financ Manage; 1986 Apr; 40(4):29-37. PubMed ID: 10300594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An overview of DRG regulations--the impact of changing reimbursement patterns.
    Morgan LB; Kappel CA
    Top Health Care Financ; 1985; 11(3):1-9. PubMed ID: 3920783
    [No Abstract]   [Full Text] [Related]  

  • 34. Cost accounting strategies under prospective payment system.
    McSweeney JM; Hebert MB; Holroyd RB
    Top Health Care Financ; 1985; 11(3):28-46. PubMed ID: 3920785
    [No Abstract]   [Full Text] [Related]  

  • 35. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2007 rates; fiscal year 2007 occupational mix adjustment to wage index; health care infrastructure improvement program; selection criteria of loan program for qualifying hospitals engaged in cancer-related health care and forgiveness of indebtedness; and exclusion of vendor purchases made under the competitive acquisition program (CAP) for outpatient drugs and biologicals under part B for the purpose of calculating the average sales price (ASP). Final rules and interim final rule with comment period.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2006 Aug; 71(160):47869-8351. PubMed ID: 16921666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. More work needed. DRGs--a progress report from the provider viewpoint.
    Barnard C; Esmond T
    Hosp Financ Manage; 1982 Jan; 36(1):48-40, 52, 54-8. PubMed ID: 10309533
    [No Abstract]   [Full Text] [Related]  

  • 37. The impact of reimbursement changes for intracoronary stents on providers and Medicare.
    Vaitkus PT
    Am J Manag Care; 1998 Aug; 4(8):1097-102. PubMed ID: 10182885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hospitals and DRGs.
    Wilson PA
    Mich Hosp; 1983 Oct; 19(10):7-10. PubMed ID: 10310401
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of case-mix adjustment on admission-based reimbursement.
    Kinzer D; Warner M
    Health Serv Res; 1983; 18(2 Pt 1):209-32. PubMed ID: 6409840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-per-case reimbursement: a challenge to hospital management.
    Bassett JG
    Top Health Rec Manage; 1984 Mar; 4(3):1-9. PubMed ID: 10310487
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.